The emerging approach of this peptide represents a exciting advance in the handling of the condition. Distinct from existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide106468.prublogger.com/40827408/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment